Pieris Pharmaceuticals Price to Free Cash Flow Ratio 1970-1969 | PVLA
Historical price to free cash flow ratio values for Pieris Pharmaceuticals (PVLA) since 1970.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pieris Pharmaceuticals Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2024-12-20 |
12.05 |
|
inf |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|